Skip to main content
Signal8

Enovis CORP (ENOV)

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Medical - Devices

Enovis Corporation logo

Enovis Corporation

NYSE:ENOVHealthcare
-12.71%$19.91
AH$19.91+0.00%vs close
Mkt Cap$1.15B
Float56M
O/S57.67M
Vol
$ Vol
RVOL
Inst Own-
SI20.9%
Earnings
Dilution
Trials4 trials as collaborator·2 active0 completed(no lead-sponsored trials found)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
  • Not applicable
    Suspended

    Enovis High Ankle Sprain Brace Testing

    Collaborator · Lead: University of Wisconsin, Madison

    Ankle tape, Standard lace-up ankle brace

    Athletes in Cutting Sports

    Enrollment
    30
    Start
    Oct 2026est.
    Primary Completion
    May 2027est.
    Completion
    May 2027est.
    NCT06719609
  • Not applicable
    Recruiting

    ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA

    Collaborator · Lead: Rush University Medical Center

    ROAM OA Single Upright Knee Brace, Ossur Unloader One Knee Brace or Standard of Care

    Knee Osteoarthritis

    Enrollment
    30
    Start
    Apr 2026
    Primary Completion
    Apr 2027est.
    Completion
    Apr 2027est.
    NCT07224958
  • Not applicable
    Recruiting

    Poly vs Hybrid Glenoid in Stemless aTSA

    Collaborator · Lead: Spaarne Gasthuis

    Anatomic total shoulder arthroplasty with cemented all-polyethylene pegged glenoid, Anatomic total shoulder arthroplasty with hybrid trabecular titanium central-peg glenoid

    Glenohumeral Osteoarthritis

    Enrollment
    94
    Start
    Jun 2025
    Primary Completion
    Jul 2035est.
    Completion
    Dec 2036est.
    NCT07520721
  • Not applicable
    Not yet recruiting

    Photobiomodulation Therapy for Pain Control in Post-Operative Total Knee Arthroplasty Patients: A Pilot Study

    Collaborator · Lead: Mohammad Burney, MD

    LightForce XLI

    Pain Management, TKA +2

    Enrollment
    15
    Start
    Aug 2026est.
    Primary Completion
    Jul 2027est.
    Completion
    Jul 2028est.
    NCT07750912